Бізнес · 19.10.20231 хв читання
American Regent, Inc., et al.; Withdrawal of Approval of Eight Abbreviated New Drug Applications
Локальний автоматичний переклад · Оригінальна мова джерела
Короткий зміст
The Food and Drug Administration (FDA or the Agency) is withdrawing approval of eight abbreviated new drug applications (ANDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.